The global Allergy Rapid Test Market was valued at USD 2.3 billion in 2024 and is projected to reach USD 4.1 billion by 2032, exhibiting a CAGR of 8.3% from 2025 to 2032. This growth is driven by rising allergy prevalence, increasing demand for point-of-care diagnostics, and technological advancements in testing methods. Report Sample includes:- Table of Contents- List of Tables & Figures- Chart..
